Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Petros Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 19 | 21 | +2 |
| Shares | 812.7K | 1.08M | +262.8K (+32.3%) |
| Value | $1.82M | $3.58M | +$1.76M (+96.2%) |
New holders (9)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 342,900 | $1.14M | 0.01% |
| Marshall Wace, LLP | 244,080 | $813.0K | 0.00% |
| Susquehanna International Group, LLP | 67,640 | $225.0K | 0.00% |
| Virtu Financial LLC | 53,019 | $177.0K | 0.02% |
| State Street Corp | 44,600 | $149.0K | 0.00% |
| Squarepoint Ops LLC | 35,814 | $119.0K | 0.00% |
| Northern Trust Corp | 13,705 | $46.0K | 0.00% |
| Two Sigma Advisers, LP | 12,000 | $40.0K | 0.00% |
| Two Sigma Securities, LLC | 10,494 | $35.0K | 0.01% |
Sold out (7)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Shay Capital LLC | 277,737 | $555.0K |
| NorthRock Partners, LLC | 115,295 | $431.0K |
| CM Management, LLC | 100,000 | $200.0K |
| Renaissance Technologies LLC | 54,347 | $109.0K |
| Platform Technology Partners | 44,000 | $88.0K |
| Neville Rodie & Shaw Inc | 21,875 | $44.0K |
| Citadel Advisors LLC | 10,367 | $21.0K |